Results 191 to 200 of about 12,125 (226)
Some of the next articles are maybe not open access.
Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)
BACKGROUND AND OBJECTIVES Antiplatelet therapy is recommended as the standard treatment for patients with acute ischemic stroke (AIS) who, for several reasons, did not receive thrombolysis or thrombectomy.
M. P. D. de Oliveira +6 more
semanticscholar +1 more source
BACKGROUND AND OBJECTIVES Antiplatelet therapy is recommended as the standard treatment for patients with acute ischemic stroke (AIS) who, for several reasons, did not receive thrombolysis or thrombectomy.
M. P. D. de Oliveira +6 more
semanticscholar +1 more source
Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)
INTRODUCTION Tirofiban is a fast-acting glycoprotein IIb-IIIa inhibitor that inhibits the final common pathway to platelet aggregation and has been studied as adjuvant therapy for acute ischemic stroke (AIS).
Gabriel de Almeida Monteiro +10 more
semanticscholar +1 more source
INTRODUCTION Tirofiban is a fast-acting glycoprotein IIb-IIIa inhibitor that inhibits the final common pathway to platelet aggregation and has been studied as adjuvant therapy for acute ischemic stroke (AIS).
Gabriel de Almeida Monteiro +10 more
semanticscholar +1 more source